InsidersTradesSigma
Jiangsu Hengrui Pharmaceuticals Co., Ltd.: management transactions · Hong Kong · HKEX
HKEX:jiangsu-hengrui-pharmaceuticals-co-ltd-h-sharesHK·HKEXMcap 419.5Bn€Healthcare
Browse the full management transaction log of Jiangsu Hengrui Pharmaceuticals Co., Ltd., a listed issuer based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co., Ltd. has logged 7 public disclosures. Market capitalisation: €419.5bn. The latest transaction was disclosed on 29 April 2026 — Other. Among the most active insiders: Lou Liguang. The full history is openly available.
7
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
5 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
63.20 €
Analyst consensus
10 analystsBuy
69.91 €Target 96.80 €(+53%)136.24 €
Income statement
Revenue31.63 Bn€
Gross profit27.27 Bn€86% margin
Net income7.71 Bn€24.9% margin
Valuation
PER (trailing)44.8x
PER (forward)39.2x
P/Book5.8x
Beta0.17
Balance sheet & cash
Market cap419.47 Bn€
Total debt74.2 M€
Free Cash Flow8.27 Bn€
Debt / Equity0%
Profitability & ownership
ROE14.5%
ROA8.8%
% insiders0.0%
% institutions72.0%
Last declaration on 29 April 2026
Declarations7 total
7 of 7 declarations